Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph DeSimone

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Experimental Hematology|February 28, 2017
Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell diseaseRamasamy Jagadeeswaran, Benjamin A Vazquez, Muthusamy Thiruppathi, et al.
The Annals of Thoracic Surgery|August 14, 2002
Long-term survival of dialysis patients after coronary bypass graftingLawrence J Dacey, Jean Y Liu, John H Braxton, et al.
The Journal of Infectious Diseases|October 31, 2002
Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapyJoseph Kulkosky, Giuseppe Nunnari, Miguel Otero, et al.
Blood|December 14, 2011
Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabineDonald Lavelle, Kestis Vaitkus, Yonghua Ling, et al.
Blood|June 3, 2015
The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell miceShuaiying Cui, Kim-Chew Lim, Lihong Shi, et al.
British Journal of Haematology|December 17, 2013
Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemiaSantosh L Saraf, Xu Zhang, Tamir Kanias, et al.
The Annals of Thoracic Surgery|December 11, 2017
Should Diabetes Be a Contraindication to Bilateral Internal Mammary Artery Grafting?Alexander Iribarne, Benjamin M Westbrook, David J Malenka, et al.
Plos Medicine|September 8, 2017
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 studyRobert Molokie, Donald Lavelle, Michel Gowhari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 7, 2026
Microneedle array platforms for drug delivery and biomarker sensing: From skin mechanics guided design to scalable manufacture for clinical utilityJiachi Zhou, Lei Wu, Minna Wyttenbach, et al.
Retina (Philadelphia, Pa.)|August 16, 2024
HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 ContinentsSwathi Kaliki, Vijitha S Vempuluru, Komal Rajendra Bakal, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Experimental Hematology|February 28, 2017
Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell diseaseRamasamy Jagadeeswaran, Benjamin A Vazquez, Muthusamy Thiruppathi, et al.
The Annals of Thoracic Surgery|August 14, 2002
Long-term survival of dialysis patients after coronary bypass graftingLawrence J Dacey, Jean Y Liu, John H Braxton, et al.
The Journal of Infectious Diseases|October 31, 2002
Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapyJoseph Kulkosky, Giuseppe Nunnari, Miguel Otero, et al.
Blood|December 14, 2011
Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabineDonald Lavelle, Kestis Vaitkus, Yonghua Ling, et al.
Blood|June 3, 2015
The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell miceShuaiying Cui, Kim-Chew Lim, Lihong Shi, et al.
British Journal of Haematology|December 17, 2013
Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemiaSantosh L Saraf, Xu Zhang, Tamir Kanias, et al.
The Annals of Thoracic Surgery|December 11, 2017
Should Diabetes Be a Contraindication to Bilateral Internal Mammary Artery Grafting?Alexander Iribarne, Benjamin M Westbrook, David J Malenka, et al.
Plos Medicine|September 8, 2017
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 studyRobert Molokie, Donald Lavelle, Michel Gowhari, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 7, 2026
Microneedle array platforms for drug delivery and biomarker sensing: From skin mechanics guided design to scalable manufacture for clinical utilityJiachi Zhou, Lei Wu, Minna Wyttenbach, et al.
Retina (Philadelphia, Pa.)|August 16, 2024
HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 ContinentsSwathi Kaliki, Vijitha S Vempuluru, Komal Rajendra Bakal, et al.
Pageof 6